2seventy bio, Inc.

NASDAQ:TSVT

4.71 (USD) • At close September 13, 2024
Bedrijfsnaam 2seventy bio, Inc.
Symbool TSVT
Munteenheid USD
Prijs 4.71
Beurswaarde 242,555,250
Dividendpercentage 0%
52-weken bereik 1.535 - 6.4
Industrie Biotechnology
Sector Healthcare
CEO Mr. Nick Leschly
Website https://www.2seventybio.com

An error occurred while fetching data.

Over 2seventy bio, Inc.

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has

Vergelijkbare Aandelen

Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

NAUT

2.9 USD

Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc.

KPTI

0.764 USD

Immatics N.V. logo

Immatics N.V.

IMTX

12.68 USD

Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

ATRA

9.72 USD

Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

ARCT

20.75 USD

Cara Therapeutics, Inc. logo

Cara Therapeutics, Inc.

CARA

0.263 USD

Immunovant, Inc. logo

Immunovant, Inc.

IMVT

29.67 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

3.6 USD

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

37.51 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)